Depletion of USP15 increased, while overexpression of USP15 reduced the resistance of CML cells to Imatinib, suggesting that USP15 may function as a tumor suppressor in CML and involve in Imatinib resistance. The gene discussed is USP15; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.